Reactivity of a monoclonal antibody with human ovarian carcinoma.
Robert C. Bast(The University of Texas MD Anderson Cancer Center), Robert C. Knapp(Brigham and Women's Hospital), Lee M. Nadler(Dana-Farber Cancer Institute), Robert B. Colvin(Harvard University), Herbert Lazarus(Harvard University Press), Maryellen Feeney(Harvard University Press)
Cited by 1,674
Related Papers
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
|American Journal of Transplantation|2008|1.9k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology
|Kidney International|1993|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k